NRX-101 (D-cycloserine plus lurasidone) vs. lurasidone for the maintenance of initial stabilization after ketamine in patients with severe bipolar depression with acute suicidal ideation and behavior: a randomized prospective phase 2 trial

Abstract Background We tested the hypothesis that, after initial improvement with intravenous ketamine in patients with bipolar disorder (BD) with severe depression and acute suicidal thinking or behavior, a fixed-dose combination of oral D-cycloserine (DCS) and lurasidone (NRX-101) can maintain imp...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Andrew Nierenberg, Philip Lavin, Daniel C. Javitt, Richard Shelton, Michael T. Sapko, Sanjay Mathew, Robert E. Besthof, Jonathan C. Javitt
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	SpringerOpen 2023-08-01
Sarja:	International Journal of Bipolar Disorders
Aiheet:	Bipolar disorder Depression Suicidal ideation Ketamine Lurasidone Hydrochloride Cycloserine
Linkit:	https://doi.org/10.1186/s40345-023-00308-5
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!